Skip to Main Content

Paper Details

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Biomark Res
173
2015
BRCA1, BRCA2, Cancer, Cancers, DNA repair, DNA repair deficiency, DNA repair-deficient cancers, Ovarian and triple-negative breast cancers, PARP, cancer, genomic, homologous recombination deficiency, patients, platinum, telomeric, tumors
Author NameAffiliation
Francesco FaveroCenter for Biological Sequence Analysis, Technical University of Denmark
Andrea L RichardsonBrigham and Women's Hospital
  • 1 - 2

Datasets

Release 1.2